Improve walking speed and stability
- Trial ID
- NCT07105787
- Official Title
- Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna
- Goal
- Improve walking speed and stability
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Kiel
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease, Falls
- Interventions
- SDTT + VR triggered adaptations, Speed-dependent treadmill training (SDTT)
Plain-Language Summary
The goal is to reduce falls and make everyday walking steadier by improving gait stability and adaptability in people with Parkinson's who already have trouble walking. The approach uses speed-dependent treadmill training, where the treadmill automatically matches and challenges your walking speed to retrain step timing and balance, combined with virtual-reality triggered changes that force quick adjustments so your brain and muscles learn to respond better; it is a rehabilitation program that complements usual Parkinson's medications rather than replacing them. They are looking for adults diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least a mild gait problem on the MDS‑UPDRS, who can walk one floor and do not have major cognitive impairment, severe depression, an implanted DBS device, or other health issues that make unsupervised exercise unsafe.
Locations
- Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying SDTT + VR triggered adaptations. The goal is to reduce falls and make everyday walking steadier by improving gait stability and adaptability in people with Parkinson's who already have trouble walking. The approach uses speed-dependent treadmill training, where the treadmill automatically matches and challenges your walking speed to retrain step timing and balance, combined with virtual-reality triggered changes that force quick adjustments so your brain and muscles learn to respond better; it is a rehabilitation program that complements usual Parkinson's medications rather than replacing them. They are looking for adults diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least a mild gait problem on the MDS‑UPDRS, who can walk one floor and do not have major cognitive impairment, severe depression, an implanted DBS device, or other health issues that make unsupervised exercise unsafe.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.